26 June 2026, Friday
24 June 2026, Wednesday
25 June 2026, Thursday
26 June 2026, Friday
27 June 2026, Saturday
- TIME TABLE
- BOSPHORUS HALL
- TOPKAPI HALL
- GALATA HALL
- TAKSİM HALL
- KADIKÖY HALL
- A3 ROOM
- STONE Amphitheatre
- CASE 1
- CASE 2
- BEBEK POSTER HALL
- MODA POSTER HALL
- BEŞİKTAŞ POSTER HALL
| 26 June 2026, Friday | ||||||||||||
| BOSPHORUS HALL | TOPKAPI HALL | GALATA HALL | TAKSİM HALL | KADIKÖY HALL | A3 ROOM | STONE Amphitheatre | CASE 2 | BEBEK POSTER HALL | MODA POSTER HALL | BEŞİKTAŞ POSTER HALL | ||
| 07:00-07:30 | EPC PANCREATIC CANCER RUN, Caddebostan Beach 07:00-08:30 |
07:00-07:30 | ||||||||||
| 07:30-08:30 | EPC Public Affairs Committe | Börek with the Professors | 07:30-08:30 | |||||||||
| 08:30-09:45 | Translational Breakthroughs in Pancreatology & EPC -Lifetime Achievement Award Lecture & Palade Prize Lecture | Why Pediatric to Adult Integration Matters in Pancreatic Diseases | Hands-On Workshop | 08:30-09:45 | ||||||||
| 09:45-10:15 | 09:45-10:15 | |||||||||||
| 10:15-10:45 | Satellite Symposium | COFFEE BREAK & SPONSORS EXHIBITION | EPC & JPS |
10:15-10:45 | ||||||||
| 10:45-13:00 | Live Advanced-EUS & Extended EUS Procedures | Best Abstracts Cystic Tumors & PanNET | The Fatty Pancreas International Consensus Report: Lessons Learned and Roadmap for the Future | TRANSPAN | Hands-On Workshop | 10:45-13:00 | ||||||
| 13:00-14:00 | LUNCH BREAK & POSTER ROUNDS & SPONSORS EXHIBITION | 13:00-14:00 | ||||||||||
| 14:00-15:45 | Early Detection & Treatment of Pancreatic Cancer | Best Abstracts Pancreatitis & Endoscopy |
Best Abstracts Varia-II |
PANDoRA Consortium | Hands-On Workshop | 14:00-15:45 | ||||||
| 15:45-16:15 | Satellite Symposium | IAP – General Assembly | COFFEE BREAK & SPONSORS EXHIBITION | 15:45-16:15 | ||||||||
| 16:15-17:00 | Rudolf Ammann & Best Abstracts Awardee Session | Hands-On Workshop | 16:15-17:00 | |||||||||
| 17:00-18:30 | EPC – General Assembly | 17:00-18:30 | ||||||||||
| BOSPHORUS HALL | ||
| 08:30-08:50 | IAP Palade Prize Lecture | Chairs: Vinciane Rebours, (Paris, France), Min Li (Oklahoma City, USA) |
| Acinar Cells: at the Heart of the Pancreas – and Mine | Francisco X. Real (Madrid, Spain) | |
| 08.50-09.55 |
Translational Breakthroughs in Pancreatology | Chairs: Roland Rad (Munich, Germany), Min Li (Oklohoma City, USA), Reiner Heuchel (Stockholm, Sweden) |
| 08.50-09.03 | Decoding Pancreatic Cancer Ecosystems with Single-Cell and Spatial Omics | William L. Hwang (Boston, USA) |
| 09.03-09.16 | Genotype-Guided Treatment of Pancreatic Cancer: Exploiting DNA Repair and Stromal Vulnerabilities | Alexander Kleger (Ulm, Germany) |
| 09.16-09.29 | Vulnerabilities, and Clinical Translation | Raghu Kalluri (Houston, USA) |
| 09.29-09.42 | Decoding Pancreatic Carcinogenesis: Genomic Roadmaps from Precursor Lesions to Invasive Cancer | Laura D. Wood (Baltimore, USA) |
| 09.42-09.55 |
Best Translational Abstracts Local delivery of CAR T cells using fibrin glue enables cellular immunotherapy for pancreatic ductal adenocarcinoma |
Tengis Tschaidse (Munich ,Germany) |
| 09.55-10.15 | EPC – Lifetime Achievement Awardee Lecture | Chairs: Güralp O. Ceyhan (Istanbul, Turkiye), Gabriele Carpuso (Milan, Italy) |
| Why Basic & Translational Research is Dependent on the Clinician’s Eye – Even from a Surgeon! | Helmut Friess (Munich, Germany) | |
| 10.15-10.45 | Coffee Break | Satellite Symposium (during the Coffee Break) |
| 10.45-13.00 | Live Advanced EUS & Extended EUS Procedures | Chairs: Albrecht Neeße (Göttingen, Germany), Andrew Metz (Melbourne, Australia), Dilek Oğuz, (Ankara, Turkey) |
| 10.45-11.00 | Global Perspective & Consensus: Expanding Roles of EUS Interventions within Surgical Care Pathways – Where are the Limits? | Andrew Metz (Melbourne, Australia) |
| 11.00-11.30 | Live Endoscopy (Patient 1) | Gürhan Sisman (Istanbul, Türkiye) & Pieter Hindryckx (Gent, Belgium) |
| 11.30-11.45 | EUS-Guided Phosphorus-32 Intratumoral Brachytherapy in Locally Advanced PDAC: Redefining Local Control & Downstaging Potential | Stefano F. Crino (Verona, Italy) |
| 11.45-12.15 | Live Endoscopy (Patient 2) | Gürhan Sisman (Istanbul, Türkiye) & Pieter Hindryckx (Gent, Belgium) |
| 12.15-12.30 | Artificial Intelligence in Pancreatic EUS: Where do We Stand? | Adrian Saftoiu (Craiova, Romania) |
| 12.30-13.00 | Live Endoscopy (Patient 3) | Gürhan Sisman (Istanbul, Türkiye) & Pieter Hindryckx (Gent, Belgium) |
| 13.00-14.00 | Lunch | |
| 14.00-15.45 | Early Detection & Treatment in Pancreatic Cancer | Chair: Shounak Majumder (Rochester,USA), Masayuki Sho (Nara, Japan), Mert Erkan (Istanbul, Turkiye) |
| 14.00-14.14 | Liquid Biopsy for Early Detection of Pancreatic Cancer and Its Impact on Treatment Monitoring and Guiding | Shounak Majumder (Rochester,USA) |
| 14.14-14.28 | MRI or EUS – What is the Best Modality to Screen for Early Pancreatic Cancer | Stephen Philcox (President of Australian Pancreatic Club) (Newcastle, Australia) |
| 14.28-14.42 | Multidisciplinary Approaches and Survival Benefits of Surgery in Locally Advanced Pancreatic Cancer | İhsan Ekin Demir (Munich, Germany) |
| 14.42-14.56 | Advanced Preoperative Imaging Techniques in Assessing Tumor Resectability Post-Neoadjuvant Therapy: Is Maging Ready to Help Us? | Rickmer Braren (Hamburg, Germany) |
| 14.56-15.10 | Triangle & Advanced Vascular Resection in LAPC – Why It is a Must in LAPC Surgery? | Shailesh Shrikhande (Mumbai, India) |
| 15.10-15.30 | When Resection then Minimally Invasive or Open? – what DIPLOMA Showed Us | Marc G. Besselink (Amsterdam, Netherlands) |
| 15.30-15.45 | Optimal Dose of Pancreatic Enzyme Replacement Therapy (PERT) for Pancreatic Exocrine Insufficiency (PEI) in Different Pancreatic Diseases: European PEI Registry: Final Results | Juan Enrique Dominguez Munoz (Santiago de Compostela, Spain) |
| 15.45-16.15 | Coffee Break | Satellite Symposium (during the Coffee Break) |
| 16.15-17.00 | Rudolf Ammann & Best Abstracts Awardee Session | Chairs: Güralp O. Ceyhan (Istanbul, Türkiye), Gabriele Capurso (Milan, Italy), Vinciane Rebours (Paris, France), Pramod Garg (New Delhi, India) |
| 16.15-16.32 |
Rudolf Amman Award/ Nordmark Heavy metals in cigarette smoke strongly inhibit pancreatic ductal function and promote development of chronic pancreatitis |
Petra Pallagi (Szeged, Hungary) |
| 16.32-16.39 |
Best Abstract Clinical Science/EPC Normal Saline or Lactated Ringer’s Solution in Acute Pancreatitis Resuscitation: a multicenter randomized clinical trial (WATERLAND) |
Lucia Guilabert (Elche, Spain) |
| 16.39-16.46 |
Best Abstract Clinical Science/IAP Spatial Transcriptomics Reveals Molecular Trajectories and Immune Landscapes in IPMN and IPMN-derived Pancreatic Cancer |
Ming Cui (Beijing, China) |
| 16.46-16.53 |
Best Abstract Basic Science/EPC Hepatic Innervation as a Regulator of the Pre-Metastatic Niche and Liver Metastasis in Pancreatic Cancer |
Eyük Yöndem (Munich, Germany) |
| 16.53-17.00 |
Best Abstract Basic Science/IAP A stem cell-engineered immune-competent PDAC organoid reveals CAF-lineage specific therapeutic vulnerabilities |
Yujie Li (Sydney, Australia) |
| 17.00-18.30 | EPC – General Assembly | |
| TOPKAPI HALL | ||
| 08.30-09:50 | Why Pediatric to Adult Integration Matters in Pancreatic Diseases | Chairs: Sanjay Pandanaboyana (New Castle, UK), Maisam Abu-El-Heija (Cincinnati, USA) |
| 08.30-08.45 | CFTR-Associated and Other Pediatric Pancreas Diseases as a Bridge to Adult Care | József Maléth (Szeged, Hungary) |
| 08.45-09.00 | Genetic Architecture of Pancreatitis: From Childhood Presentation to Adult Chronic Disease | Andrea Geisz (Boston, USA) |
| 09.00-09.15 | Classification and Imaging of Pediatric Pancreatitis – Implications for Adult Practice | Temel Tirkes (Indianapolis, USA) |
| 09.15-09.30 | What Pediatric Cohorts Teach Us About Lifelong Pancreatic Disease | Maisam Abu-El-Haija (Cincinnati, USA) |
| 09.30-09:45 | Surgery of the Pediatric Pancreas, When It Can’t Wait till to Adolescence and What Type of Surgery then? | Sanjay Pandanaboyana (Newcastle, UK) |
| 10.15-10.45 | Coffee Break | |
| 10.45-13.00 | Best Abstracts Cystic Tumors & PanNET | Chairs: Stefano Partelli (Milan, Italy), Müjde Soytürk (Izmir, Turkiye) |
| 10:45-10:54 | Recurrence After Resection of Non-Invasive Intraductal Papillary Mucinous Neoplasms: A Multicenter Analysis of Risk Factors and Clinical Impact | Riccardo Pellegrini (Padova ,Italy) |
| 10:54-11:03 | Optimizing pancreatic cyst surveillance: a cost-effectiveness analysis using microsimulation modelling | Oliver White (Rotterdam ,The Netherlands) |
| 11:03-11:12 | Exposome and cyst features are associated with distinct histotypes and malignancy risk in surgically resected IPMNs: preliminary results from the multicenter ESPRESSO MACCHIATO study | Gabriele Capurso (Milan ,Italy) |
| 11:12-11:21 | Decoding IPMN Heterogeneity: Matched Molecular Profiling from Cyst Wall, Fluid and Plasma in the GERPACYST Registry | Matthäus Felsenstein (Berlin ,Germany) |
| 11:21-11:30 | Real-world EUS evaluation of pancreatic cystic lesions: cytology-based classification and predictors of mucinous cysts and high grade dysplasia | Charalampos Thanos (Athens ,Greece) |
| 11:30-11:39 | Clinical, demographic and EUS features of pancreatic cysts: a nationwide multicenter study of the Pancreas Working Group | |
| 11:39-11:48 | Reappraisal of the concept of “timely surgery” according to follow-up vs upfront surgery strategy for IPMNs | Riccardo Pellegrini (Padova ,Italy) |
| 11:48-11:57 | AI-based radiomics for pancreatic cysts: high diagnostic performance amid persistent translational gap | Johannes D. Lettner (Freiburg ,Germany) |
| 11:57-12:06 | Complementary ex vivo models reveal determinants of targeted therapy response in nonfunctioning pancreatic neuroendocrine tumors | Anna Battistella (Milano ,Italy) |
| 12:06-12:15 | More Parenchyma, Less Safety? Two Decades of Pancreatic Neuroendocrine Tumor Surgery | Carola Focke (Freiburg ,Germany) |
| 12:15-12:24 | IRE-centered multidisciplinary treatment for unresectable pancreatic acinar-MiNEN: durable 5-year survival in an ultra-rare pancreatic malignancy | Yingjie Wang (Zhengzhou ,China) |
| 12:24-12:33 | Multi-omics profiling of CUX1 transcription factor revealed epigenetic regulation in PanNETs: Unlocking new therapeutic targets through targeting the CUX1–HAT1/EZH2 pathway | Maryam Khosravian (Heidelberg ,Germany) |
| 12:33-12:42 | Endoscopic Photodynamic Therapy Under Direct Visualization via Pancreatoscopy: An Innovative treatment for Pancreatic MD-IPMN | Wei Liu (Changsha City ,China) |
| 12:42-12:51 | Evaluation of the treatment strategy for small non-functioning pancreatic neuroendocrine neoplasms: resection versus observation | Wataru Izumo (Yamanashi ,Japan) |
| 12:51-13:00 | Primary Tumor Resection Prior to Peptide Radionuclide Receptor Therapy Improves Survival in Metastatic Gastroenteropancreatic Neuroendocrine Tumors: A Systematic Review and Meta-analysis | Sándor Orbán (Budapest ,Hungary) |
| 13.00-14.00 | Lunch | |
| 14.00-15.45 | Best Abstracts Pancreatitis & Endoscopy | Chairs: Erkin Öztaş (Istanbul, Turkiye), Livia Archibugi (Milan, Italy) |
| 14.00-14.09 | Pain in Chronic Pancreatitis: Multidimensional associations with neuropsychological factors, neurometabolic alterations, and corticolimbic connectivity | Abdul Rasheed Mohammed (Hyderabad ,India) |
| 14.09-14.18 | Trajectories of pain processing in recurrent acute and chronic pancreatitis: a longitudinal quantitative sensory testing study | Louise Kuhlmann (Aalborg ,Denmark) |
| 14.18-14.27 | Risk of pancreatic disease in families with metabolic dysfunction-associated steatotic liver disease: a population-based multigenerational cohort study | Miroslav Vujasinovic (Stockholm ,Sweden) |
| 14.27-14.36 | Long term evolution of type 2 autoimmune pancreatitis, evidence from a large french cohort | Clémence Descourvières (Clichy ,France) |
| 14.36-14.45 | Clinical Practice of Modified Pancreatic Duct Stone Classification (Xi-Panc) in the Treatment of Chronic Pancreatitis | Xue Yang (Xi’an ,China) |
| 14.45-14.54 | Managed risk of abdominal compartment syndrome in patients with acute severe pancreatitis | Ivanna A. Shchyhel (Kyiv ,Ukraine) |
| 14.54-15.03 | Combination of non-steroidal anti-inflammatory drugs plus pancreatic duct stent placement after unintentional pancreatic duct cannulation is superior to NSAIDs alone in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis | Mike J.P. de Jong (Nijmegen ,The Netherlands) |
| 15.03-15.12 | Machine Learning versus QNI Score for Predicting Step-Up Therapy After Initial EUS-Guided Drainage of Pancreatic Fluid Collections | Marcel Razpotnik (Berlin ,Germany) |
| 15.12-15.21 | International Delphi Consensus on Training in Diagnostic and Therapeutic Endoscopic Ultrasound | Matteo Tacelli (Milano ,Italy) |
| 15.21-15.30 | Closing the ERCP quality gap: an open digital platform for real-time competency and outcome tracking | Lukas Erhart (St. Pölten ,Austria) |
| 15.30-15.39 | Redefining vascular patterns in focal lesions with EUS Detective Flow Imaging: a multicenter interobserver agreement study | Riccardo Di Pangrazio (Roma ,Italy) |
| 14.00-15.54 | Best Abstracts – Vatria II | Chairs: Aydin Seref Köksal (Ankara, Turkiye), Laura Maggino (Verona, Italy) |
| 14.00-14.09 | Small intestinal bacterial overgrowth as a possible cause of falsely reduced fecal elastase-1 levels | Natalya Gubergrits |
| 14.09-14.18 | A Patient-Reported Tool for All PEI Etiologies? Validation of the PEI-Q and Its Utility in Monitoring Response to PERT | J Enrique Dominguez Muñoz |
| 14.18-14.27 | Association between pancreatic enzyme replacement therapy and mortality in pancreatic cancer: a matched case-control study | Ana Dugic |
| 14.27-14.36 | 10-year empirical survival rates following upfront pancreatectomy for pancreatic ductal adenocarcinoma. A bi-institutional analysis | Susanna Tondato |
| 14.36-14.45 | Pre-Test Probability Drives the Diagnostic Yield of Fecal Elastase-1: A Multicenter Real-World Study | Marta Andreozzi |
| 14.45-14.54 | The mouse cancer cell line atlas reveals core principles of tissue-specific cancer evolution | Sebastian Mueller |
| 14.54-15.03 | Exocrine pancreatic insufficiency and nutritional status in resectable and borderline resectable periampullary tumors: A prospective longitudinal study | Eric Herrero Fonollosa |
| 15.03-15.12 | Whole genome sequencing-using long-reads to identify structural variants and methylation signatures in IPMN evolution into malignancy | Riccardo Farinella |
| 15.12-15.21 | Preoperative transhepatic portomesenteric venous stenting in locally advanced pancreatic cancer with venous occlusion and associated varices | Matthias Ilmer |
| 15.21-15.30 | SHP2 regulates CAF activity and adaptive stromal remodeling during vertical RAS pathway inhibition in pancreatic cancer | Steffen Johannes Keller |
| 15.30-15.39 | Predictors of fecal elastase testing completion in outpatient and inpatient settings: a single center retrospective analysis | Arjun Chatterjee |
| 15.45-16.15 | IAP – General Assembly | |
| GALATA HALL | ||
| 10.45-13.00 | International Multidisciplinary Consensus Report on Fatty Pancreas: Lessons Learned and Roadmap for the Future | Chairs: Vinciane Rebours (Paris, France), J. -Matthias Löhr (Heidelberg, Germany) |
| 10.45-10.50 | Welcome & Opening Remarks | Vinciane Rebours (Paris, France), J. -Matthias Löhr (Stockholm, Sweden) |
| 10.50-11.00 | Fatty Pancreas: Background, Consensus Methodology, and Key Concepts | Miroslav Vujasinovic (Stockholm, Sweden) |
| 11.00-11.10 | Histopathological Features of Fatty Pancreas | Aslıhan Yavaş (Dusseldorf, Germany) |
| 11.10-11.25 | Imaging Modalities and Radiological Evaluation of Fatty Pancreas | Muşturay Karçaaltıncaba (Ankara, Turkiye) |
| 11.25-11.35 | Clinical Implications of Fatty Pancreas in Acute and Chronic Pancreatitis | Pramod Garg (New Delhi, India) |
| 11.35-11.45 | Fatty Pancreas in Pancreatic Neoplasms: IPMN and PDAC Perspectives | Giovanni Marchegiani (Padova, Italy) |
| 11.45-11.55 | Metabolic Consequences of Fatty Pancreas: β-Cell Function and Glucose Regulation | Laszlo Czako (Szeged, Hungary) |
| 11.55-12.05 | Surgical Considerations and Management of Fatty Pancreas | Sanjay Pandanaboyana (New Castle, UK) |
| 12.05-12.25 | Therapeutic Strategies, Key Conclusions, and Future Directions in Fatty Pancreas Research | İhsan Ekin Demir (Munich, Germany) |
| 12.25-13.00 | Panel Discussion: Multidisciplinary Perspectives and Audience Q& | Chairs and All Speakers |
| 13.00-14.00 | Lunch | |
| KADIKÖY HALL | ||
| 10.45-13.00 | TRANSPAN | |
| 13:00-14:00 | Lunch | |
| 14:00-15.45 | PANDoRA Consortium | |
| 15:45-16:15 | Coffee Break | |
| A3 ROOM | ||
| 07.30-08.30 | EPC Public Affairs Committe | |
| 10.15-10.45 | EPC & JPS |
|
| STONE Amphitheatre | ||
| 07.30-08.30 | Börek with the Professors | |
| CASE 2 | ||
| 08.30-10.30 | Hands-On Workshop | |
| 10.30-10.45 | Coffee Break | |
| 10.45-13.00 | Hands-On Workshop | |
| 13:00-14:00 | Lunch | |
| 14:00-15.45 | Hands-On Workshop | |
| 15:45-16:15 | Coffee Break | |
| 16.30-17.00 | Hands-On Workshop | |
Bebek Poster Hall / 13.00 – 14.00 |
|||
| *Please kindly note that each presentation is allocated 4 minutes (3-minute presentation + 1-minute discussion) | |||
| AbsRef | Pub Number | Title | Presenter |
| Group – 18 | Chairs: Bo Kong, Özlem Sönmez | ||
| 384 | POTH-014 | Network-based identification of stage-specific interception points in pancreatic disease progression | Yan Bi |
| 585 | PPCC-065 | Injecting Innovation: EUS-Guided Phosphorus-32 as a Local Ablative Boost in Pancreatic Cancer Therapy | Rodrigo Montoto Meijide |
| 599 | PPCC-066 | The role of detective flow imaging- endoscopic ultrasound in the characterization of unexplained biliary strictures: a retrospective study | Leila Babaiyan |
| 606 | PPCC-067 | Beyond Presence: Patterns of Angioinvasion as Determinants of Aggressiveness in Pancreatic Ductal Adenocarcinoma | Samuele Grandi |
| 632 | PPCC-068 | Chemotherapy-induced liver injury during Neoadjuvant Treatment in Pancreatic Cancer: A Systematic Review and Meta-analysis Randomized Controlled Trials | Alessio Marchetti |
| 645 | PPCC-069 | High-grade PanIN/Carcinoma in situ Incidentally Discovered in a Resected Pancreas with IPMN: A Retrospective Radiological Review | Yoshihiro Hamada |
| 651 | PPCC-070 | Distinct Lipid Signatures in Early-Onset Pancreatic Ductal Adenocarcinoma | Liu Longyu |
| 653 | PPCC-071 | Diagnostic work-up of patients with suspected pancreatic cancer: A prospective single-centre study | Tamas Hussein |
| 654 | PPCC-072 | Tumor microbiota profiling identifies microbial signatures associated with clinical and radiological features in locally advanced pancreatic ductal adenocarcinoma | Giacomo Marcozzi |
| 660 | PPCC-073 | Prognostic impact of positive margin location after R1 pancreatic resections: a survival analysis | Orfeas Varvarelis |
| 663 | PPCC-074 | Clinical impact of positive drain fluid amylase after pancreatectomy: association with postoperative complications and hospital stay | Vasiliki Alkmini Themelidi |
| 671 | PPCC-075 | The impact of preoperative biliary drainage on the occurrence of postoperative complications after pancreaticoduodenectomy | Vladyslav Bondar |
| 677 | PPCC-076 | Giant (18 cm) primary epithelioid gastrointestinal stromal tumor of the pancreatic tail: Case Report and Literature Review | Vyronas Argyris |
| 678 | PPCC-077 | Analysis of the diagnostic utility of endosonography-guided biopsy in pancreatic solid lesions | Barbara Wlodarczyk |
| 687 | PPCC-078 | Features of pancreatic cancer in the tunisian population | Amal Khsiba |
| Group – 19 | Chairs: Daniel Öhlund, Mert Erkan | ||
| 784 | POTH-024 | Fatty changes in resected pancreatic neck | Mariia Kiriukova |
| 689 | PPCC-079 | Use of Dynamic Cell Imaging™ (DCI) with the Van Gogh Platform in EUS-guided Sampling of Pancreatic Solid Lesions: A Feasibility Pilot Study | Maria Terrin |
| 711 | PPCC-080 | A preliminary analysis of the diagnostic performance of a radiological artificial intelligence (AI) tool for the incidental detection of pancreatic lesions on computed tomography | Antonella Campisi |
| 712 | PPCC-081 | Characteristics of pancreatic ductal adenocarcinoma following acute pancreatitis: a multicentric cohort analysis on 1006 cases | Ruggero Ponz De Leon Pisani |
| 714 | PPCC-082 | Use of aspirin, statins, metformin and ace-inhibitors does not affect disease-free, disease-specific and overall survival in patients affected by pancreatic ductal adenocarcinoma | Ruggero Ponz De Leon Pisani |
| 715 | PPCC-083 | PrePANC-NT Trial: Prehabilitation in Patients with Pancreatic Cancer During Neoadjuvant Therapy; Exploring an Understudied Window | Ahmet Anil Sahar |
| 717 | PPCC-084 | The Role of Pancreatic Tumor/Remnant Tissue Density Ratio in Predicting Grade B and C POPF | Ulas Utku Sekerci |
| 718 | PPCC-085 | Perivascular regions show reduced response to neoadjuvant chemotherapy in PDAC with vascular involvement | David Zschäpitz |
| 719 | PPCC-086 | Patterns of recurrence in ampullary carcinoma – A Cross-Validation Study of the German Cancer Registry and an International Multicenter Cohort | Julia Straesser |
| 721 | PPCC-087 | Clinical significance of tumor markers CA 19-9, CA 242, CA 50 and CA 72-4 in the diagnosis and staging of pancreatic cancer | Uros Djindjic |
| 724 | PPCC-088 | Macrophage inhibitory cytokine 1, syncollin, and thrombospondin-2 in the differential diagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis | Michalina Wieczorek |
| 730 | PPCC-089 | A rare case of a 7 cm distal pancreatic ductal adenocarcinoma with a central 3 cm osseous metaplasia, oligometastatic to the liver, still alive 9 years after multi-visceral resection, excision of liver metastasis and chemotherapy | Sorin Traian Barbu |
| 734 | PPCC-090 | Endoscopic Ultrasound (EUS) Findings of Metastatic Lesions to the Pancreas: A Retrospective Single-Center Study | Nevin Oruç |
| 735 | PPCC-091 | Indications and prognostic factors in metastatic pancreatic cancer referred for radical treatment – a systematic review and meta-analysis | Chiara Maria Scandinavini |
| 736 | PPCC-092 | Efficacy of immunonutrition in hepatobiliary cancer patients – a systematic review and meta-analysis | Bettina Csilla Budai |
| 342 | PPED-001 | Is the prevalence of the exacerbations of the chronic pancreatitis related to the infectious season? | Zofia Oracz |
| Group – 20 | Chairs: Christopher Wolfgang, Orcun Can | ||
| 163 | POTH-006 | A rare case of pancreatic mass mimicking malignancy | Emine Gökce |
| 741 | PPCC-093 | Postoperative Pancreatic Fistula and Recurrence in Pancreatic Ductal Adenocarcinoma | Hüseyin Fahri Martlı |
| 745 | PPCC-094 | Liver metastasis and surgery for pancreas adenocarcinoma | Ahmet Çoker |
| 748 | PPCC-095 | Hemopatch and pancreatic fistula | Ahmet Çoker |
| 752 | PPCC-096 | High Early Recurrence Burden in Young Patients with Pancreatic Cancer Following Surgical Resection | Hüseyin Fahri Martlı |
| 757 | PPCC-097 | Diagnostic Laparoscopy in Staging Exocrine Pancreatic Cancer: An Updated Review and Recommendations | Emilija Nikolovska Trpchevska |
| 761 | PPCC-098 | Development and validation of a machine learning model predicting overall survival after resection of adenocarcinoma arising from intraductal papillary mucinous neoplasms (A-IPMN) | Christos Athanasiou |
| 762 | PPCC-099 | Resection Margin Sites and Their Impact on Oncological Outcomes in Adenocarcinoma Arising from IPMN: Results from an International Multicenter Cohort Study | Vivek Peddakota |
| 772 | PPCC-100 | The impact of neoadjuvant chemotherapy (nCT) on outcomes for patients with resectable pancreatic cancer | Ilya Vervekin |
| 773 | PPCC-101 | Contemporary Adjuvant Chemotherapy for intraductal papillary mucinous neoplasms following pancreatic resection | Vivek Peddakota |
| 774 | PPCC-102 | The “Acıbadem sandwich protocol” – a novel neoadjuvant chemoradiotherapy approach in bordeline resectable and locally advanced pancreatic cancer patients | Nur Ramoğlu |
| 785 | PPCC-103 | Primary Pancreatic Squamous Cell Carcinoma: A rare rntity with unexpected EUS findings | David Miguel Ferro Tomás |
| 799 | PPCC-104 | Comparison of Total Mesopancreatic Excision and Conventional Pancreaticoduodenectomy in the Surgical Treatment of Pancreatic Head Adenocarcinoma: Early Postoperative Outcomes | Cihan Ağalar |
| 800 | PPCC-105 | Up-front Surgery for Anatomically Borderline Resectable and Locally Advanced Pancreatic Cancer (BR/LAPC): Contemporary Real-world Outcomes | Zipeng Lu |
| 805 | PPCC-106 | Failure to Rescue After Pancreatoduodenectomy: A Single-Center Analysis Compared to GAPASURG Data | Congde Martin Xu |
| Group – 28 | Chairs: Okan Safak | ||
| 107 | POTH-001 | Highly effective but not lifelike? Prehabilitation in pancreatic surgery – Single-center experience | Matthias Glanemann |
| 141 | POTH-002 | Small intestinal bacterial overgrowth (SIBO) and colonic dysbiosis in patients with combined fatty pancreas and metabolic dysfunction-associated steatotic liver disease (MASLD) | Nadiia Bieliaieva |
| 144 | POTH-003 | The disease of Albrecht Dürer | Natalya Gubergrits |
| 148 | POTH-004 | Microbiological Profile and Antimicrobial Resistance Patterns in Walled-Off Pancreatic Necrosis: A Single-Centre Retrospective Study | Tom Brand |
| 158 | POTH-005 | Morphological patterns of inflammatory infiltration and fibrosis of the gastric mucosa in Helicobacter pylori-associated NSAID gastropathies in patients with ischemic heart disease | Almaza Madumarova |
| 243 | POTH-007 | When Is Pancreatic Cancer Surveillance Efficient? A Microsimulation Study of Test Characteristics and Lifetime Risk | Oliver White |
| 286 | POTH-010 | Pancreatic arteriovenous malformations as a manifestation of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease): a systematic review | Isabel De Jager |
| 380 | POTH-012 | The Role of Helicobacter pylori in Pancreatic and Hepatic Steatosis | Mimoza Kankia |
| 381 | POTH-013 | Surgical Anatomy of Peripancreatic Vessels in Pancreatic Resections | Spiros Delis |
| 423 | POTH-016 | Bacterial Colonization in Resected Lymph Nodes During Pancreatic Surgery – A Pilot Study | Saadet Gurcinar |
| 474 | POTH-017 | Impact of multimodal prehabilitation on postoperative outcomes after pancreatic resection: design of a prospective randomized controlled trial | Stefan Kolcun |
| 530 | POTH-018 | PancreOS: A network of registries on Pancreatic Cancer | Raquel Benitez Dorta |
| 572 | POTH-019 | Different intracellular pathways to calcium signal generation in pancreatic acinar cells activated by the cancer-promoting receptor for gastrin-releasing peptide (GRP) and by excitation of cholecystokinin (CCK) receptors | Muhanad E Salih |
| 580 | POTH-020 | Diagnostic Performance of EUS versus MRCP for Choledocholithiasis: A Systematic Review | Taibe Haziri |
| 652 | POTH-021 | Building quality improvement in HPB surgery in Ukraine: a nationwide needs assessment survey of surgeons and anesthesiologists | Inesa Huivaniuk |
| 672 | POTH-022 | Trans-anastomotic Stent After Pancreatoduodenectomy: Impact on Early Postoperative Drain Fluid Amylase | Aya Maekawa |
| 804 | POTH-025 | Fatty changes are more frequent in malignant pancreatic diseases | Mariia Kiriukova |
| Group – 33 | Chairs: Anna Caterina Milanetto | ||
| 206 | PNET-001 | Surgery or surveillance in sporadic Pancreatic Neuroendocrine Neoplasms in patients with age >= 75 years ? | Anna Caterina Milanetto |
| 207 | PNET-002 | Duodenal Neuroendocrine Neoplasms. Surgical treatment and long-term results | Anna Caterina Milanetto |
| 313 | PNET-003 | Pancreatic neuroendocrine tumor with bile duct stenosis: possible origin of the bile duct epithelium | Atsuko Kasajima |
| 377 | PNET-004 | Pancreatic Neuroendocrine Neoplasms: Surgical Results from the Hellenic Pancreatic Neuroendocrine Tumor (HELPNET) Study Group | Spiros Delis |
| 388 | PNET-005 | Laparoscopic Resection of Pancreatic Insulinoma in a Patient with Multiple Endocrine Neoplasia Type 1: A Case Report and Literature Review | Hao Luo |
| 434 | PNET-006 | Pancreatic and ampullary neuroendocrine tumors: diagnosis, staging and management at a Moroccan tertiary center | Jaouhara Lahsini |
| 458 | PNET-007 | Aurora kinase inhibition as a targeted therapy for ARID1A‑deficient gastroenteropancreatic neuroendocrine carcinoma | Maria Pacalajova |
| 598 | PNET-008 | Complex course of incidental pancreatic neuroendocrine tumor and inflammatory bowel disease with repeated surgical complications: a case report | Dóra Demeter |
| 644 | PNET-009 | Two Cases of PP-producing PanNET with Atypical Histopathology and Invasive Character | Yoshihiro Hamada |
| 698 | PNET-010 | Validation of Progression-Free Survival and Other Candidate Surrogate Endpoints for Overall Survival in Pancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis | Yuxin Wang |
Moda Poster Hall / 13.00 – 14.00 |
|||
| *Please kindly note that each presentation is allocated 4 minutes (3-minute presentation + 1-minute discussion) | |||
| AbsRef | Pub Number | Title | Presenter |
| Group – 24 | Chairs: Rup Talukdar, Kazushige Uchida | ||
| 586 | PAPC-047 | Interim results of the international LIFESPAN case–control study: lifestyle risk factors in acute pancreatitis | Dalma Dobszai |
| 601 | PAPC-048 | Physiotherapy improves the functional status and physical strength of patients hospitalized with acute pancreatitis | Bence Tibor Soós |
| 612 | PAPC-049 | Development and International Validation of a Deep Learning Model for Acute Pancreatitis Severity | Brigitta Teutsch |
| 617 | PAPC-050 | Microbiological profile and temporal shifts in infected pancreatic necrosis in acute pancreatitis: A single-center descriptive study | Rodrigo Montoto Meijide |
| 635 | PAPC-051 | A randomized, placebo-controlled phase 3 study of plozasiran in patients with familial chylomicronemia syndrome: PALISADE – 1 year open-label extension | Maciej Banach |
| 637 | PAPC-052 | Plozasiran decreases the risk of acute pancreatitis and may improve quality of life in Familial Chylomicronemia Syndrome | Maciej Banach |
| 638 | PAPC-053 | Lipase Over Amylase in Acute Pancreatitis: A 1,293-Case Retrospective | Paula Filipa Rebelo |
| 640 | PAPC-054 | When Lipase Fails: Predictors of False-Negative Acute Pancreatitis | Paula Filipa Rebelo |
| 643 | PAPC-055 | Economic Impact of a Lipase-Only Diagnostic Strategy in Acute Pancreatitis: A Cost Modelling Analysis | Paula Filipa Rebelo |
| 650 | PAPC-056 | Advances in the prediction of acute pancreatitis severity using machine learning models | Ying Lu Huang |
| 674 | PAPC-057 | Incidence and severity of pancreatic exocrine insufficiency in acute pancreatitis during hospitalization: a prospective observational study | Jingwen Rao |
| 675 | PAPC-058 | Transgastric endoscopic necrosectomy alone for pancreatic necrosis extending to the paracolic gutter in necrotizing pancreatitis: a retrospective cohort study | Jingwen Rao |
| 691 | PAPC-059 | Local complications as the only criterion to define moderately severe acute pancreatitis | Juan Lin |
| 692 | PAPC-060 | Pancreas Divisum: Experience of a Tunisian Center | Amal Khsiba |
| 694 | PAPC-061 | Low-enzyme acute pancreatitis and the limitations of current diagnostic guidelines | Gefu Cai |
| 98 | PISL-001 | Determinants of Islet Yield and Long-Term Metabolic Outcomes After Total Pancreatectomy With Islet Autotransplantation | Javed Latif |
| 99 | PISL-002 | Comparative Outcomes of Total Pancreatectomy with Islet Autotransplantation in Hereditary Versus Non-Hereditary Chronic Pancreatitis: A 30-Year Single-Centre Study | Javed Latif |
| Group – 25 | Chairs: Yasar Colak | ||
| 720 | PAPC-062 | UICENS Strategy for Treating Infected Pancreatic Necrosis: A 10-Year Single-Center Experience from China | Hao Luo |
| 727 | PAPC-063 | Inflammatory and hematological markers and clinical outcomes in hypertriglyceridemia-related acute pancreatitis: a nationwide multicenter cohort study | Yavuz Özden |
| 728 | PAPC-064 | When Drugs Attack the Pancreas: Unmasking a Hidden Cause of Acute Pancreatitis | Ekram Hassan Hasanin |
| 732 | PAPC-065 | Clinical Characteristics, Timing, and Outcomes of Atypical Hemolytic Uremic Syndrome in Acute Pancreatitis: An Individual Patient-Level Analysis | Boglárka Barna |
| 737 | PAPC-066 | Red Cell Distribution Width at 24 Hours as an Early Predictor of Mortality and Severity in Acute Pancreatitis: A Multicenter Retrospective Cohort Study | Mihai Radu Pahomeanu |
| 739 | PAPC-067 | Prognostic Value of Red Cell Distribution Width to Platelet Ratio in Acute Pancreatitis – A Multicenter Registry-Based Cohort Study | Mihai Radu Pahomeanu |
| 740 | PAPC-068 | Day 1 Nucleated Red Blood Cell Count as a Prognostic Biomarker in Acute Pancreatitis: a Preliminary Result of a Multicenter Retrospective Cohort Study | Mihai Radu Pahomeanu |
| 744 | PAPC-069 | Endosonographic differentiation of acute necrotizing pancreatitis and tumor-induced pancreatitis in the acute phase | Elena Mateska |
| 749 | PAPC-070 | Nutritional status at admission and clinical outcomes in acute pancreatitis: a prospective observational cohort study | Olga Julia Zahariev |
| 753 | PAPC-071 | Role of Lanreotide in the Management of Complex Pancreatic Fluid Collections: A Retrospective Review | Mudassar Ghazanfar |
| 759 | PAPC-072 | Male sex is associated with worse outcomes in acute pancreatitis: post-hoc analysis of the WATERLAND randomized trial | Lucía Guilabert |
| 777 | PAPC-073 | Machine Learning-Based Risk Stratification in Acute Pancreatitis: Development of a Balanced Random Forest Model for Predicting Severity of Pancreatitis and Critical Care Admission | Christos Athanasiou |
| 778 | PAPC-074 | Depression, Anxiety, and Outcomes in Acute Pancreatitis: A Prospective Observational Study | Tibor Dániel Fehér |
| 796 | PAPC-075 | Effect of methionine containing antioxidant cocktail on recurrence of acute pancreatitis in children | Pullara Kashif Suleman |
| 100 | PISL-003 | Portal venography and portal venous pressure assessment following total pancreatectomy and islet autotransplantation using a recanalised umbilical vein catheter | Javed Latif |
| 161 | PISL-004 | A 30-Year Multidisciplinary Framework for Assessment and Consent in Total Pancreatectomy with Islet Autotransplantation | Javed Latif |
| 769 | PISL-007 | Islet autotransplantation in pancreatic trauma: evaluating feasibility, safety, and metabolic outcomes after pancreatic resection | Sanjay Pandanaboyana |
| Group – 26 | Chairs: Yasar Colak, Giovanni Marchegiani | ||
| 102 | PCYS-001 | Obesity as a Risk and Prognostic Factor for Disease Progression in Intraductal Papillary Mucinous Neoplasm (IPMN): A Systematic Review and Meta-analysis | Charlotte Gustorff |
| 152 | PCYS-003 | Assessing surveillance for branch duct IPMN: Number needed to screen and standardized incidence ratio analysis | Julia Moghadampour |
| 237 | PCYS-004 | Treatment of Pancreatic Pseudocysts Under Endosonographic Guidance | Igor Khomiak |
| 263 | PCYS-005 | Pancreatic acinar cell cystadenoma: single-center experiences and a systematic review | Miroslav Vujasinovic |
| 346 | PCYS-007 | Risk factors associated with high-grade dysplasia and adenocarcinoma in mucinous cystic neoplasm of the pancreas | Alejandro Gutierrez Castillo |
| 610 | PSUR-048 | Unraveling the protective effect of female sex on outcome after pancreatoduodenectomy: less complications or smaller impact? for the Dutch Pancreatic Cancer Group | Greta Donisi |
| 621 | PSUR-049 | Comparison of surgery outcomes for pancreatic ductal adenocarcinoma according to tumour location: eleven years of experience in a tertiary hospital | Núria Llorach Perucho |
| 622 | PSUR-050 | Comparison of pancreaticoduodenectomy with and without mesenteric-portal venous resection in pancreatic ductal adenocarcinoma: 11 years of experience in a tertiary institution | Francisco Garcia Borobia |
| 626 | PSUR-051 | Standardising Extravasation Injury Management: A Retrospective Audit & Future Improvements | Berin Gorgun |
| 636 | PSUR-052 | The impact of inflammation and biliary microbiology on postoperative morbidity after cholecystectomy – a single-center retrospective cohort study | Patrick Hofmockel |
| 646 | PSUR-053 | Perioperative transfusions of blood products and the effect on postoperative morbidity and mortality in pancreatic head resections- A unicenter, retrospective analysis | Isabel Kraemer |
| 659 | PSUR-054 | The burden of vascular resection in pancreatic surgery: myth or reality | Vanessa Cusano |
| 667 | PSUR-055 | Preoperative GNRI fails to predict clinically relevant postoperative pancreatic fistula after pancreatoduodenectomy and distal pancreatectomy for PDAC: an external validation study | Miguel Fróis Borges |
| 668 | PSUR-056 | Artificial intelligence–derived inflammatory and nutritional profiles identify high-risk patients undergoing pancreatic cancer resection | Miguel Fróis Borges |
| Group – 27 | Chairs: Johanna Laukkarinen, Sohei Satoi | ||
| 639 | PCYS-011 | Scoping review of cost-effectiveness of surveillance of intraductal papillary mucinous neoplasms | Dana Sochorova |
| 670 | PCYS-012 | ATHENA: A Multimodel AI Decision-Support Tool for Multidisciplinary Evaluation of Pancreatic Cysts | Claudio Ricci |
| 747 | PCYS-013 | MACHINE-LEARNING-POWERED ENDOSCOPIC ULTRASOUND DETECTS MORPHOLOGICAL FEATURES FOR PREDICTING MALIGNANCY IN IPMNs: RESULTS FROM THE “IMAGE” STUDY FROM A TERTIARY REFERRAL CENTER | Matteo Tacelli |
| 750 | PCYS-014 | Can we predict biopsy accuracy in IPMNs? Preoperative prediction of cytology-histology concordance combining EUS-FNA and a machine learning approach | Matteo Tacelli |
| 802 | PCYS-015 | Single-center experience with endoscopic management of demarcated walled-off pancreatic necrosis (WOPN) | Dominik Horváth |
| 669 | PSUR-057 | Frailty predicts postoperative mortality in pancreatic resection for cancer | Miguel Fróis Borges |
| 681 | PSUR-058 | Intraoperative Indocyanine Green Angiography to Prevent Functional Deficit after Tail-Preserving Pancreatectomy – An Experience of a Tertiary Care Centre of Nepal | Prabir Maharjan |
| 682 | PSUR-059 | CRP kinetics and NLR as early predictors of clinically relevant POPF following pancreatic surgery | Mario Gruppo |
| 704 | PSUR-060 | Toward mechanically realistic pancreatic surgery simulation: multi-modal characterization of relevant tissues | Arianna Callera |
| 707 | PSUR-061 | Concomitant Major Complication (CMC) score defines postoperative trajectories and outcomes after Pancreatoduodenectomy | Alice Cattelani |
| 725 | PSUR-062 | Simultaneous or staged liver resection in the treatment of synchronous colorectal cancer metastases | Predrag Zdujic |
| 731 | PSUR-063 | Pancreatic metastases: retrospective case series from a tertiary referral center | Konstantinos Iliakopoulos |
| 767 | PSUR-064 | Comparison of different types of pancreatic anastomoses after pancreaticoduodenectomy (modified Blumgart anastomosis vs invagination pancreaticojejunostomy) | Ilya Vervekin |
| 794 | PSUR-065 | Double roux reconstruction to reduce pancreatobiliary reflux and its potential role in preventing malignancy after pancreatoduodenectomy | Eylül Köseler |
| Group – 31 | Chairs: Jayanta Samanta, Miroslav Vujasinovic | ||
| 526 | PCYS-008 | Elevated CA19-9 is a good predictor of adverse long-term outcomes after pancreatic resection for adenocarcinoma arising from IPMN. Results from an international multicenter cohort study | Vivek Peddakota |
| 536 | PCYS-009 | Rethinking the Role of Acute Pancreatitits in Intraductal Papillary Mucinous Neoplasms: A Multicenter Evaluation of Radiologic, Clinical, and Biological Predictors of Neoplastic Progression | Riccardo Pellegrini |
| 238 | PCYS-010 | Risk Stratification of Malignancy in Pancreatic Intraductal Papillary Mucinous Neoplasm Using 2024 Kyoto Guidelines: Impact of Worrisome Features | Jisun Lee |
| 614 | PEND-032 | EUS-Guided gastroenterostomy versus enteral stenting for malignant gastric outlet obstruction in pancreatic cancer: A real-world comparative study | Sofía Barral Diaz |
| 615 | PEND-033 | Choosing the Optimal EUS-Guided Drainage in Malignant Distal Biliary Obstruction: Choledochoduodenostomy vs gallbladder drainage | José Lariño Noia |
| 673 | PEND-034 | From Pixels to Decision-Making: Utilizing Multi-scale Attention and Self-supervised Baseline Models to Achieve Pathologist Cognitive Workflow in Pancreatic ROSE | Jie Hao |
| 696 | PEND-035 | Microbial Profile of Bile Cultures in Patients with Cholangitis Undergoing Endoscopic Retrograde Cholangiopancreatography (ERCP): A Systematic Review and Meta-Analysis | Yoon Kee Beck |
| 701 | PEND-036 | EUS-guided HepaticoGastrostomy in pancreatobiliary malignancies: prospective assessment of efficacy and safety according to indication and anatomy | Roberto Junior Ruggiero |
| 766 | PEND-038 | Clinical outcomes of EUS-guided multiple transluminal gateway drainage for walled-off pancreatic necrosis and pseudocysts: a single-center experience | Patryk Kaczor |
| 781 | PEND-039 | Thirty-day hospital admission following Outpatient ERCP: Safety Profile and Predictive Factors | David Miguel Ferro Tomás |
| 787 | PEND-040 | Safety and efficacy of precut techniques for biliary cannulation in Outpatient ERCP | David Miguel Ferro Tomás |
| 577 | PIMG-003 | Comparative assessment of pancreatic stiffness in fatty pancreas vs. healthy controls using ultrasound elastography | Emilija Nikolovska Trpchevska |
| 716 | PIMG-005 | Radiomics and Artificial Intelligence in Pancreatic Endoscopic Ultrasound: Can We Detect Cancer Before It Becomes Visible? | Irina Florina Cherciu Harbiyeli |
| Group – 32 | Chairs: Stephen Pandol | ||
| 182 | PEDI-001 | Clinical significance and accuracy of continuous glucose monitoring in pancreatectomy patients | Yoo Jin Choi |
| 250 | PEDI-002 | Real-world evaluation of suspected pancreatic exocrine insufficiency and generation of a reasonable workup – a cohort study from a large pancreatic disease center in Germany | Jakob Vielhauer |
| 142 | PEPI-002 | Exocrine pancreatic insufficiency or lactase deficiency: differential diagnosis | Nadiia Bieliaieva |
| 150 | PEPI-004 | Long-term Nutritional Outcomes After Distal Pancreatectomy for Benign Pancreatic Cysts: Impact of Pancreatic Enzyme Replacement Therapy | Yoonchan Lee |
| 205 | PEPI-006 | Pancreatic exocrine insufficiency after esophageal and gastric surgery: the PEGAS study | Miroslav Vujasinovic |
| 281 | PEPI-007 | Comparative renal effectiveness of newer glucose-lowering drugs with metformin in new-onset diabetes after pancreatitis patients: a target trial emulation cohort study | Di Wu |
| 307 | PEPI-008 | Features of exocrine insufficiency in long-term follow-up after proximal pancreatic resection | Yulia Osipenko |
| 318 | PEPI-009 | Symptoms of Pancreatic Exocrine Insufficiency Correlate with Stool Consistency Rather Than EUS Findings | Joowon Chung |
| 371 | PEPI-010 | Diagnostic Performance and Cost Implications of Fecal Elastase in Evaluating Steatorrhea and Exocrine Pancreatic Dysfunction | Motaz Ashkar |
| 421 | PEPI-011 | Low bone mineral density and fracture risk in chronic pancreatitis: The impact of pancreatic exocrine insufficiency | Andreia Rei |
| 583 | PEPI-013 | Familial fatty pancreas due to transheterozygous mutations in MECOM and CELA3B | Maren Ewers |
| 611 | PEPI-014 | Risk factors for pancreatic exocrine insufficiency after acute pancreatitis: a systematic review and meta-analysis | Orsolya Eperjesi |
| 791 | PEPI-017 | Pancreatic Exocrine Insufficiency as a Marker of Disease Progression in IPMN Surveillance: IPEX Study | Giacomo Deiro |
Beşiktaş Poster Hall / 13.00 – 14.00 |
|||
| *Please kindly note that each presentation is allocated 4 minutes (3-minute presentation + 1-minute discussion) | |||
| AbsRef | Pub Number | Title | Presenter |
| Group – 21 | Chairs: Andrea Geisz-Fremy | ||
| 482 | PPCE-049 | Interim outputs of the United Kingdom Early Detection Initiative for pancreatic cancer | Lucy Oldfield |
| 484 | PPCE-050 | Deciphering the Genomic Drivers of Neural Invasion in Pancreatic Cancer | Basak Kavaklioglu |
| 488 | PPCE-051 | A circulating protein signature of pancreatogenic disease detectable up to five years before pancreatic cancer diagnosis | Irena Stefanova |
| 489 | PPCE-052 | An advanced preclinical model for testing combination therapy in pancreatic cancer using a dynamic culture platform | Verona Buocikova |
| 494 | PPCE-053 | ROR1 Expression in Lymph Nodes, Tumor Tissue, and Immune Cells as a Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma | Anke Mittelstädt |
| 498 | PPCE-054 | Deep learning–driven identification of peripherally restricted NPY1R antagonists to disrupt nerve-tumor crosstalk in pancreatic ductal adenocarcinoma | Esra Nalbat |
| 510 | PPCE-055 | Integrative molecular analysis of pancreatic cancer precursor lesions: predictive models for biological aggressiveness and tumor development | Raka Aziz |
| 531 | PPCE-057 | Decitabine reshapes the transcriptional response to gemcitabine in orthotopic MIAPaCa-2 pancreatic cancer xenografts | Bozena Smolkova |
| 533 | PPCE-058 | Targeting VMP1 to Overcome Chemotherapy Resistance in Pancreatic Ductal Adenocarcinoma | Maria Ines Vaccaro |
| 551 | PPCE-060 | GLOPH3-ERK1/2-E2F1 positive feedback loops promote pancreatic cancer progression | Wang Zheng |
| 552 | PPCE-061 | The Fas receptor promotes neural invasion by inducing a shift from apoptotic to migratory signaling in pancreatic cancer | Clara M. Müller |
| 553 | PPCE-062 | Integrated Single-Cell Analysis Identifies CD55 as a Mediator of Neoadjuvant Chemotherapy Resistance in PDAC | Zongyao Chen |
| 575 | PPCE-063 | Schwann Cell derived Chromosome 4 Chemokines modulate Cancer Cell Viability | Mara R Goetz |
| 576 | PPCE-064 | Knock-out of mitophagy receptors Bnip3 and Nix results in increased therapy response of murine pancreatic cancer cells | Simon Knoll |
| 587 | PPCE-065 | Immunomodulatory impact of PTPN11/SHP2-based vertical RAS-MAPK pathway inhibition in pancreatic cancer | Asma Alrawashdeh |
| Group – 22 | Chairs: Heiko Witt | ||
| 590 | PPCE-066 | Genome-wide CRISPR/cas9 screening for oxaliplatin resistance in pancreatic cancer | Jung Won Chun |
| 603 | PPCE-067 | Micro-CT analysis can distinguish features of PDAC: preliminary experience | Kaisa Tyrväinen |
| 604 | PPCE-068 | Multi-trait genome-wide association analysis identifies novel susceptibility loci for pancreatic cancer | Yongping Chen |
| 609 | PPCE-069 | Multinucleated giant cells in human pancreatic cancer are a distinct macrophage population undergoing a DNA damage response and associated to an aggressive tumor microenvironment | Greta Donisi |
| 623 | PPCE-070 | The CTRB2del Variant Confers Increased Risk of Pancreatic Ductal Adenocarcinoma in the Hungarian Population | Sarah Ammar Khodja |
| 628 | PPCE-071 | Combating Chemoresistance in Pancreatic Cancer: Insights from Transcriptomics and dCK-Independent Therapy | Giulia Lencioni |
| 629 | PPCE-072 | The roles of Galnt2 and St3gal6 genes on neural invasion in pancreatic cancer | Alper Dogruoz |
| 634 | PPCE-073 | Integrative CUT&RUN and RNA-seq Analyses Reveal STAT3-Dependent Regulatory Networks in IL-17–Stimulated Pancreatic Acinar Cells | Mahnoosh Ostadreza |
| 641 | PPCE-074 | Exosome-driven schwann cell–cancer cell communication promotes pancreatic cancer aggressiveness | Didem Karakas |
| 647 | PPCE-075 | The impact of RNF43 mutation on the tumor-stroma crosstalk during earlier pancreatic carcinogenesis | Matthäus Felsenstein |
| 648 | PPCE-076 | The mechanism of macrophage-induced PDAC cell senescence driven by ENO1-mediated histone lactation driving pancreatic cancer stemness | Luying Huang |
| 664 | PPCE-077 | Early neural remodeling initiates at the Acinar-to-Ductal Metaplasia stage in pancreatic carcinogenesis | Alper Dogruoz |
| 697 | PPCE-079 | Background. Pancreatic ductal adenocarcinoma (PDAC) is characterized by an aggressive clinical course and profound immunotherapy resistance, driven largely by an immunosuppressive tumor microenvironment (TME) dominated by tumor-associated macrophages | Svetlana M. Gramatiuk |
| 700 | PPCE-080 | Significance of lncRNAs in diagnosis and prognosis of pancreatic cancer | Nevin Oruc |
| 703 | PPCE-081 | Which sugar is sweeter for pancreatic cancer? | Nevin Oruc |
| Group – 23 | Chairs: Didem Karakas Zeybek, Ivonne Regel | ||
| 297 | PGEN-002 | Germline genetic variants associated with chemotherapy response and survival in non-metastatic pancreatic ductal adenocarcinoma | Manuel Gentiluomo |
| 461 | PGEN-003 | Rare variant analysis suggests ASIC2 and KCNJ2 as candidate genes for pancreatic cancer risk in the UK Biobank cohort study | Emma Barreto |
| 602 | PGEN-005 | Dissecting pancreatic ductal adenocarcinoma genetic architecture through fine-mapping of susceptibility loci | Cosmeri Rizzato |
| 630 | PGEN-007 | Refining Pancreatic Cancer Surveillance Through Context-Aware Germline Variant Interpretation | William Greenhalf |
| 662 | PGEN-009 | NR5A2–CTRB2 genetic interaction increases PDAC risk by impairing pancreatic stress responses | Sarah Klauss |
| 746 | PGEN-010 | Clinical Relevance of Germline CHEK2 and CDKN2A Variants in Pancreatitis and Pancreatic Cancer | Stanislaw Zbigniew Gluszek |
| 793 | PGEN-012 | The role of extrachromosomal DNAs (ecDNAs) in chemocytotoxic resistance in pancreatic cancer | Sadaf Shabbir Mughal |
| 722 | PPCE-082 | The lncRNA within small extracellular vesicles promotes the neuron-cancer crosstalk in pancreatic cancer | Linhan Ye |
| 723 | PPCE-083 | Single-cell profiling identifies MMP1-high inflammatory CAFs associated with neoadjuvant chemotherapy resistance in pancreatic ductal adenocarcinoma | Yihong Cai |
| 733 | PPCE-084 | Neuropeptide Y Promotes Tumor–Nerve Crosstalk and Neural Invasion in Pancreatic Ductal Adenocarcinoma | Shenghan Wang |
| 756 | PPCE-085 | Visualizing pancreatic neural structures using Golgi-Cox staining method | Alper Dogruoz |
| 764 | PPCE-086 | Mechanisms for stroma-induced secondary chemoresistance in pancreatic adenocarcinoma | Corinne Bousquet |
| 771 | PPCE-087 | LAMA3 and LAMA4 are upregulated and prognostically significant in pancreatic cancer | Nevin Oruc |
| 775 | PPCE-088 | NOL4 is a tumor suppressor gene that plays critical role in chronic pancreatitis related oncogenesis | Nevin Oruc |
| 792 | PPCE-089 | Tumor-Educated Platelets Acquire PDAC-Associated RNA: A Multicohort Diagnostic Signature with in vitro Confirmation | Aldo Pastore |
| 798 | PPCE-090 | Deep learning–enabled multiomics reveals neural drivers of perineural invasion in PDAC | Raphael Kfuri Rubens |
| Group – 29 | Chairs: Ujjwal Mahajan, Yetiş Gültekin | ||
| 208 | PAPE-001 | Mitigating organ failure with a novel oral anti-lipase treatment targeting gut lymph in experimental severe acute pancreatitis | John Windsor |
| 227 | PAPE-002 | Proteomic Profiling Reveals Distinct Sex-Specific Molecular Mechanisms and Inflammatory Pathways in Severe Acute Pancreatitis | Aditi Bhargava |
| 233 | PAPE-003 | Effects of GLP-1 Receptor Agonists on Secretagogue-induced Acute Pancreatitis in Mice | Rebecca Reardon Lochbaum |
| 270 | PAPE-004 | Extracellular vesicle–mediated inflammation in acute pancreatitis is attenuated by Lactated Ringer’s solution: involvement of protein lactylation | Olga Armengol Badia |
| 277 | PAPE-005 | Pancreatic tissue remodeling in experimental pancreatitis is regulated by activation and recruitment of systemic immune cells via the CXCR3 chemokine system | Juliane Glaubitz |
| 325 | PAPE-006 | Differential regulation of pancreatic duct HCO3– secretion by inflammatory cytokines | Mingjuan Li |
| 328 | PAPE-007 | Role of the ER-cargo protein CLN8 in the pathophysiology of acute pancreatitis | Lukas Zierke |
| 379 | PAPE-008 | The inhibition of matrix-metalloproteases restricts the immune cell infiltration and ameliorates the disease severity in acute pancreatitis | Shenja Buchholz |
| 401 | PAPE-010 | GLP-1 receptor agonists induce non-inflammatory pancreatic hypertrophy and ameliorate acute pancreatitis in mice | Zhengyang Fan |
| 414 | PAPE-011 | Interleukin-1 family cytokines regulate pancreatic fibroblast activation and immune cell recruitment in experimental acute pancreatitis | Ben Lewin Becker |
| 451 | PAPE-012 | Expression and Functional Role of H2S-Producing Enzymes in Pancreatic Acinar Cell Injury | Erik Orján |
| 456 | PAPE-013 | Mitigating ferroptosis-induced cellular damage in mouse pancreatic acinar cells | Bálint Sándor |
| 483 | PAPE-014 | Hepatic metabolite N-acetylaspartic acid alleviates acute pancreatitis by restoring mitophagy via BCL2L13 | Shiyu Liu |
| 516 | PAPE-015 | Body Mass Index and Psychological Alterations in Patients with Acute Pancreatitis | Zsofia Nemeth |
| 676 | PAPE-016 | Therapeutic Inhibition of Pancreatic Triglyceride Lipase Ameliorates Hypertriglyceridemic Pancreatitis in mice | Jingwen Rao |
| 742 | PAPE-017 | The pancreatic phenotype of CftrΔpanc mice is driven by the ductal compartment | Henrik Einwächter |
| Group – 30 | Chairs: Raghu Kalluri | ||
| 160 | PCPE-001 | Therapeutic targeting of secreted osteopontin attenuates fibrogenesis in experimental chronic pancreatitis | Emine Gökce |
| 175 | PCPE-002 | Immune-related gene signatures and immune cell infiltration in chronic pancreatitis: an integrated bioinformatics analysis | Xiaobo Wang |
| 248 | PCPE-003 | Plasminogen activator inhibitor-1 as a Potential Antifibrotic Target in Chronic Pancreatitis | Tünde Molnár |
| 276 | PCPE-004 | Cholesterol-Mediated communications between acinar cells and β cells in chronic pancreatitis | Yitian Zhou |
| 293 | PCPE-005 | Aptamer-aided anti-inflammatory programming of resident tissue macrophages for recuperation of chronic pancreatitis | Jianying Xu |
| 301 | PCPE-006 | Decoding Mesenchymal Control of Chronic Pancreatitis via Prrx1⁺ Lineage Tracing and Single-Cell Profiling | Ruoxuan Dai |
| 339 | PCPE-007 | The management of pancreaticopleural fistulas: a single centre case series | Madhav Sanatkumar Dave |
| 375 | PCPE-008 | Investigating changes in endocrine function in a mouse model of chronic pancreatitis | Gergely Koszta |
| 455 | PCPE-009 | Restoring ductal CFTR function as a disease-modifying strategy in chronic pancreatitis | Tamara Madácsy |
| 466 | PCPE-010 | Impact of TRPA1 on Acute Injury and Fibrotic Remodeling in Pancreatitis | Ola Salamah |
| 471 | PCPE-011 | A high-fat diet is insufficient to drive pancreatic intraepithelial neoplasia from acinar-to-ductal metaplasia | Cecile Haumaitre |
| 486 | PCPE-012 | IL-4/IL-13/STAT6 signalling regulates fibrogenesis and organ regeneration via suppression of the IL-6/STAT3 pathway during chronic pancreatitis | Matthias Sendler |
| 490 | PCPE-013 | Production of Anti-CX3CR1 Monoclonal Antibody for Use in the Preclinical Treatment of Chronic and Acute Pancreatitis | Tayyar Emir Gözeler |
| 538 | PCPE-014 | Pancreatitis leaves an epigenetic imprint on acinar cells that shapes regeneration and plasticity | Yiming Zhang |
| 658 | PCPE-015 | A CX3CL1–CX3CR1–Driven Neuro-Immune Circuit Amplifies Pain in Pancreatitis and Offers a Druggable Therapeutic Entry Point | Ibrahim Halil Gürcinar |
| 751 | PCPE-016 | APOBEC3A is a molecular link between chronic inflammation and immune activation, driving a feed-forward loop that exacerbates pancreatic injury and promotes mutagenesis | Intisar Salim |
| 782 | PCPE-017 | Re-evaluating the role of TRPV6 deficiency in human and mouse pancreatitis | Mate Sandor |
